Hoth Therapeutics Stock Analysis

HOTH -  USA Stock  

USD 1.09  0.05  4.39%

The current Hoth Therapeutics price drop may raise some interest from stockholders. The stock closed today at a share price of 1.09 on 231,058 in trading volume. The company directors and management were unable to exploit market volatilities in September. However, diversifying your overall positions with Hoth Therapeutics can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 2.76. The current volatility is consistent with the ongoing market swings in September 2021 as well as with Hoth Therapeutics unsystematic, company-specific events.
Please check Risk vs Return Analysis.

Hoth Therapeutics Stock Analysis 

The Hoth Therapeutics stock analysis report makes it easy to digest most publicly released information about Hoth Therapeutics and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Hoth Therapeutics Stock analysis module also helps to analyze the Hoth Therapeutics price relationship with some important fundamental indicators such as market cap and management efficiency.

Hoth Therapeutics Stock Analysis Notes

About 16.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.3. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hoth Therapeutics recorded a loss per share of 0.68. The entity had not issued any dividends in recent years. Hoth Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for dermatological disorders. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York. Hoth Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. To learn more about Hoth Therapeutics call the company at 646 756 2997 or check out

Hoth Therapeutics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Hoth Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Hoth Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Hoth Therapeutics generated a negative expected return over the last 90 days
Hoth Therapeutics has some characteristics of a very speculative penny stock
Hoth Therapeutics has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (10.41 M).
Hoth Therapeutics currently holds about 17.43 M in cash with (7.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Hoth Therapeutics has a frail financial position based on the latest SEC disclosures
Roughly 16.0% of the company shares are held by company insiders
Latest headline from Hoth gains 1.79 percent for October 21 -

Hoth Therapeutics Upcoming and Recent Events

Earnings reports are used by Hoth Therapeutics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Hoth Therapeutics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report9th of November 2021
Next Earnings Report15th of March 2022
Next Fiscal Quarter End30th of September 2021
Next Fiscal Year End15th of March 2022
Last Quarter Report30th of June 2021
Last Earning Announcement30th of September 2020

Hoth Therapeutics Largest EPS Surprises

Earnings surprises can significantly impact Hoth Therapeutics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Hoth Therapeutics SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Hoth Therapeutics prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Hoth Therapeutics investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Hoth Therapeutics specific information freely available to individual and institutional investors to make a timely investment decision.
1st of September 2021
Financial Statements and Exhibits. Other Events
26th of August 2021
Other Events
30th of June 2021
Financial Statements and Exhibits. Other Events. Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
17th of June 2021
Other Events
24th of May 2021
Financial Statements and Exhibits. Other Events
7th of May 2021
Other Events
15th of April 2021
Other Events
18th of March 2021
Unclassified Corporate Event

Hoth Therapeutics Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 26.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hoth Therapeutics's market, we take the total number of its shares issued and multiply it by Hoth Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Hoth Therapeutics Profitablity

Hoth Therapeutics' profitability indicators refer to fundamental financial ratios that showcase Hoth Therapeutics' ability to generate income relative to its revenue or operating costs. If, let's say, Hoth Therapeutics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Hoth Therapeutics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Hoth Therapeutics' profitability requires more research than a typical breakdown of Hoth Therapeutics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(1.20) (1.30) 
Return on Average Equity(1.33) (1.43) 
Return on Invested Capital(4.61) (4.73) 

Management Efficiency

The entity has return on total asset (ROA) of (51.26) % which means that it has lost $51.26 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (88.95) %, meaning that it created substantial loss on money invested by shareholders. Hoth Therapeutics management efficiency ratios could be used to measure how well hoth therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. The current Return on Average Assets is estimated to decrease to -1.3. The current Return on Average Equity is estimated to decrease to -1.43. The current Total Assets is estimated to decrease to about 4.4 M. The current Current Assets is estimated to decrease to about 4 M
Last ReportedProjected for 2021
Book Value per Share 0.38  0.32 
Enterprise Value over EBIT(4.00) (4.32) 
Enterprise Value over EBITDA(3.85) (4.16) 
Price to Book Value 6.86  10.56 
Tangible Assets Book Value per Share 0.42  0.39 
Enterprise Value27.7 M32.9 M
Tangible Asset Value5.2 M4.4 M

Technical Drivers

As of the 25th of October, Hoth Therapeutics retains the market risk adjusted performance of (1.55), and Risk Adjusted Performance of (0.08). Hoth Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Hoth Therapeutics, which can be compared to its competitors. Please check out Hoth Therapeutics information ratio, potential upside, as well as the relationship between the Potential Upside and kurtosis to decide if Hoth Therapeutics is priced fairly, providing market reflects its last-minute price of 1.09 per share. Given that Hoth Therapeutics is a hitting penny stock territory we urge to closely look at its total risk alpha.

Hoth Therapeutics Price Movement Analysis

The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Instantaneous Trendline is a moving-average-like indicator which is formed by removing the Dominant Cycle from Hoth Therapeutics price series. View also all equity analysis or get more info about hilbert transform instantaneous trendline overlap studies indicator.

Hoth Therapeutics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Hoth Therapeutics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Hoth Therapeutics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Hoth Therapeutics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Hoth Therapeutics Technical and Predictive Indicators

Hoth Therapeutics Forecast Models

Hoth Therapeutics time-series forecasting models is one of many Hoth Therapeutics' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Hoth Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Hoth Therapeutics Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Hoth Therapeutics stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hoth Therapeutics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Hoth Therapeutics. By using and applying Hoth Therapeutics Stock analysis, traders can create a robust methodology for identifying Hoth Therapeutics entry and exit points for their positions.
Hoth Therapeutics, Inc., a biopharmaceutical company, focuses on developing therapies for dermatological disorders. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York. Hoth Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.

Current Hoth Therapeutics Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Hoth Therapeutics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Hoth Therapeutics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
10.0Strong Buy1Odds
Hoth Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Hoth Therapeutics analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Hoth Therapeutics stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Hoth Therapeutics, talking to its executives and customers, or listening to Hoth Therapeutics conference calls.
Hoth Therapeutics Analyst Advice Details

Hoth Therapeutics Stock Analysis Indicators

Hoth Therapeutics stock analysis indicators help investors evaluate how Hoth Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Hoth Therapeutics shares will generate the highest return on investment. By understating and applying Hoth Therapeutics stock analysis, traders can identify Hoth Therapeutics position entry and exit signals to maximize returns.
Quick Ratio14.29
Fifty Two Week Low1.0600
Shares Short Prior Month785.13k
Average Daily Volume Last 10 Day392.33k
Average Daily Volume In Three Month442k
Shares Percent Shares Out0.41%
Short Percent Of Float0.43%
Forward Price Earnings-1.87
Float Shares19.59M
Fifty Two Week High3.5000
Enterprise Value To Ebitda-0.96
Fifty Day Average1.2234
Two Hundred Day Average1.4087
Please check Risk vs Return Analysis. Note that the Hoth Therapeutics information on this page should be used as a complementary analysis to other Hoth Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Hoth Therapeutics Stock analysis

When running Hoth Therapeutics price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Is Hoth Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth Therapeutics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth Therapeutics that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Hoth Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.